| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3055 | |||||||||||||||||||||||
| Submitter : | Mr. Timothy Miller | Date & Time: | 12/12/2006 09:12:06 | |||||||||||||||||||||
| Organization : | none | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| Dear sirs & madams,
I urge you to consider the many, including myself who will refuse treatment with product lines originating from aborted fetal stem cells. Please encourage the use of alternate stem cell sources in any and every way so that no one is unnecessarily forced to choose between conscience and health care. Thank You, Timothy B. Miller | ||||||||||||||||||||||||